Mcao Model
Mcao Model - Related Videos
06:38
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
0 Views •
2025
To simulate thromboembolic stroke, emboli prepared from heterologous rat blood were injected into the middle cerebral artery, followed by administration of systemic thrombolysis for recanalization. This version of the model is optimized for use in a multi-laboratory network and supports testing multiple candidate therapeutics.
13:01
Intraluminal Middle Cerebral Artery Occlusion (MCAO) Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Mice
0 Views •
Cited by 76 •
2011
The intraluminal middle cerebral artery occlusion (MCAO) model is the most frequent used model among experimental ischemic stroke models. Here we will demonstrate the entire model in detail with the guide of Laser Doppler flowmetry, and its representative results.
09:40
Mouse Model of Intraluminal MCAO: Cerebral Infarct Evaluation by Cresyl Violet Staining
0 Views •
Cited by 97 •
2012
The intraluminal middle cerebral occlusion model in mice is herein presented. The extent of cerebral infarct is evaluated by a neurologic score and cresyl violet staining, an alternative staining to TTC, offering the great advantage to test in parallel many interest markers.
09:11
Embolic Middle Cerebral Artery Occlusion (MCAO) for Ischemic Stroke with Homologous Blood Clots in Rats
0 Views •
Cited by 25 •
2014
In this paper, we demonstrate a standard method for producing an embolic middle cerebral artery occlusion with homologous blood clots (fibrin-rich) in adult rat. This model closely mimics human ischemic stroke and is suitable for preclinical study of thrombolytic therapy for ischemic stroke.
06:28
Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model
0 Views •
Cited by 194 •
2011
Filamentous occlusion of the Middle cerebral artery is a common model for studying ischemic stroke in mice.
FAQs
Maintaining the obstruction models sustained focal ischemia, allowing investigators to examine infarct development and neurological deficits caused by restricted blood flow. Removing the obstruction adds a reperfusion phase, which can be used to study reperfusion injury and tissue responses after flow is restored. This distinction helps separate effects associated with ischemia from those associated with subsequent reperfusion.
The model supports assessment of several linked consequences of focal cerebral ischemia, including infarct development, neurological deficits, inflammation, blood-brain barrier disruption, and tissue recovery. Examining these outcomes together provides a broader picture than measuring tissue damage alone. It also allows investigators to connect functional changes with inflammatory, vascular, and recovery-related responses in the affected brain region.
Controlled restriction of blood flow to regions supplied by the middle cerebral artery creates a defined setting for examining stroke-related changes. This experimental control helps researchers evaluate how ischemia affects brain tissue and neurological function, then compare those outcomes across potential interventions. The approach is therefore useful for linking a specific vascular event with measurable injury and recovery endpoints.
A typical experiment introduces an occluding filament or another obstruction and positions it within the middle cerebral artery to restrict blood flow. Investigators may then maintain the obstruction to study ischemia or remove it to model reperfusion injury. Subsequent evaluation focuses on infarct development, neurological deficits, inflammation, blood-brain barrier disruption, or tissue recovery.
Researchers can use this model when they need to evaluate potential neuroprotective drugs, surgical strategies, or rehabilitation approaches under experimentally produced ischemic stroke conditions. The resulting measurements help determine whether an intervention influences infarct development, neurological deficits, inflammation, barrier disruption, or recovery. Findings can support decisions about which approaches warrant further investigation before clinical testing.
Its relevance comes from combining a controlled ischemic event with outcomes that matter clinically and biologically. Investigators can examine both neurological deficits and tissue-level responses, including infarction, inflammation, blood-brain barrier disruption, and recovery. This combination helps connect experimental treatment effects to stroke mechanisms and supports preclinical assessment of therapies, procedures, and rehabilitation strategies before clinical evaluation.